Article citationsMore>>

A. Forero-Torres, J. Shah, T. Wood, J. Posey, R. Carlisle, C. Copigneaux, F. R. Luo, S. Wojtowicz-Praga, I. Percent, and M. Saleh, “Phase I Trial of Weekly Tigatuzumab, an Agonistic Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5),” Cancer Biotherapy & Radiopharmaceuticals, Vol. 25, No. 1, 2010, pp. 13-19. http://dx.doi.org/10.1089/cbr.2009.0673

has been cited by the following article:

• TITLE: Development of Small Molecules Activating TRAIL Apoptosis Pathway for Cancer Therapies

  AUTHORS: Anita C. Bellail, Chunhai Hao

  KEYWORDS: Apoptosis Pathway; Apoptosis Pathway

  JOURNAL NAME: Open Journal of Apoptosis, Vol.2 No.4, October 31, 2013

  ABSTRACT: Development of Small Molecules Activating TRAIL Apoptosis Pathway for Cancer Therapies